Timothy Scannell

Timothy Scannell

Net worth: 5 M $ as of 30/05/2026

61 year
Health Technology
Technology Services
Consumer Services

Profile

Presently, Timothy J. Scannell is Independent Chairman of Insulet Corp. He is also on the board of NovoCure Ltd. and President & Chief Operating Officer for Stryker Corp. In the past he occupied the position of Vice President & General Manager at Stryker Spine and Vice President & General Manager at Stryker Biotech LLC. Mr. Scannell received an MBA and an undergraduate degree from the University of Notre Dame.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
19/05/2026 33,024 ( 0.05% ) 5 M $ 30/05/2026
02/06/2026 25,898 ( 0.02% ) 441 302 $ 30/05/2026

Timothy Scannell active positions

CompaniesPositionStart
INSULET CORPORATION Chairman 31/12/2018
NOVOCURE LIMITED Director/Board Member 04/02/2021
Director/Board Member 30/01/2022
Chairman 19/06/2023
Director/Board Member 31/05/2022
Director/Board Member -

Former positions of Timothy Scannell

CompaniesPositionEnd
MASIMO CORPORATION Director/Board Member 09/06/2026
EXACT SCIENCES CORPORATION Director/Board Member 12/06/2024
MOLEKULE GROUP, INC. Director/Board Member 29/02/2024
░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
See the detail of Timothy Scannell's experience

Training of Timothy Scannell

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

95

1st degree connections

16

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies16

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Technology Services

Technology Services

Producer Manufacturing

  1. Stock Market
  2. Insiders
  3. Timothy Scannell
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!